Zimmer Biomet (Imaging & Robotics)
U.S.-based global medical-device company — third-largest orthopedic-implant maker globally alongside Stryker and DePuy Synthes (Johnson & Johnson). Imaging / robotics footprint within the broader portfolio is the ROSA robotic surgical platform for orthopedic and neurosurgical applications. Direct competitor to Stryker Mako, Smith & Nephew CORI, and DePuy VELYS in the orthopedic-robotics category.
Company history
- 1927 — Zimmer founded in Warsaw, Indiana.
- 2015 — Zimmer + Biomet merger forms Zimmer Biomet.
- 2016 — acquires Medtech SA (ROSA Brain neurosurgical robotics).
- 2019 — ROSA Knee robotic-arthroplasty platform launches.
- 2020s — ROSA Knee installed base grows; ROSA Hip extends platform.
Product line (imaging / robotics)
Orthopedic robotics
- ROSA Knee — robotic-assisted total knee arthroplasty.
- ROSA Hip — robotic-assisted total hip arthroplasty.
- ROSA Brain — neurosurgical / spine robotic platform (predecessor / sibling).
Implants + instruments
- Outside scope of the imaging vault.
Distinctive technology
- ROSA Knee — large-arm robotic-arthroplasty platform; supports both CT-based and imageless workflow options.
- Real-time intra-operative bone-tracking — ROSA arm-mounted optical / infrared tracking.
- Persona Knee implant integration — Zimmer Biomet's flagship implant family is workflow-paired with ROSA Knee planning.
Market position
Top-three orthopedic-robotics vendor alongside Stryker Mako (dominant) and Smith & Nephew CORI. ROSA Knee is rapidly growing in joint-arthroplasty programs as a Mako alternative; ROSA Brain has smaller dedicated neurosurgical / spine robotic installed base.
Refurb posture
- Vendor-led service contracts dominate; secondary-market activity limited.
- Implant-tied workflow — ROSA Knee installs typically pair with Persona implant adoption; switching robotics doesn't trivially decouple the implant choice.